NRIX
Price
$25.10
Change
-$0.71 (-2.75%)
Updated
Sep 11 closing price
Capitalization
2.61B
27 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$24.59
Change
-$1.56 (-5.97%)
Updated
Sep 11 closing price
Capitalization
3.13B
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs RCUS

NRIX vs RCUS Comparison Chart in %
View a ticker or compare two or three
VS
NRIX vs. RCUS commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and RCUS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($3.13B) has a higher market cap than NRIX($2.61B). NRIX YTD gains are higher at: 32.314 vs. RCUS (3.189). NRIX has higher annual earnings (EBITDA): -343.92M vs. RCUS (-439M). RCUS has more cash in the bank: 702M vs. NRIX (444M). NRIX has less debt than RCUS: NRIX (58.1M) vs RCUS (114M). RCUS has higher revenues than NRIX: RCUS (117M) vs NRIX (36.8M).
NRIXRCUSNRIX / RCUS
Capitalization2.61B3.13B83%
EBITDA-343.92M-439M78%
Gain YTD32.3143.1891,013%
P/E RatioN/AN/A-
Revenue36.8M117M31%
Total Cash444M702M63%
Total Debt58.1M114M51%
FUNDAMENTALS RATINGS
NRIX vs RCUS: Fundamental Ratings
NRIX
RCUS
OUTLOOK RATING
1..100
6970
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3539
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NRIX's Valuation (46) in the null industry is in the same range as RCUS (73) in the Pharmaceuticals Major industry. This means that NRIX’s stock grew similarly to RCUS’s over the last 12 months.

NRIX's Profit vs Risk Rating (100) in the null industry is in the same range as RCUS (100) in the Pharmaceuticals Major industry. This means that NRIX’s stock grew similarly to RCUS’s over the last 12 months.

NRIX's SMR Rating (98) in the null industry is in the same range as RCUS (98) in the Pharmaceuticals Major industry. This means that NRIX’s stock grew similarly to RCUS’s over the last 12 months.

NRIX's Price Growth Rating (35) in the null industry is in the same range as RCUS (39) in the Pharmaceuticals Major industry. This means that NRIX’s stock grew similarly to RCUS’s over the last 12 months.

RCUS's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as NRIX (100) in the null industry. This means that RCUS’s stock grew similarly to NRIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NRIXRCUS
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend about 1 month ago
81%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (NRIX: $25.10 vs. RCUS: $24.59)
Brand notoriety: NRIX and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 120% vs. RCUS: 345%
Market capitalization -- NRIX: $2.61B vs. RCUS: $3.13B
NRIX [@Biotechnology] is valued at $2.61B. RCUS’s [@Biotechnology] market capitalization is $3.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green while RCUS’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while RCUS’s TA Score has 5 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 4 bearish.
  • RCUS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both NRIX and RCUS are a good buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а -3.98% price change this week, while RCUS (@Biotechnology) price change was -17.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2026.

RCUS is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
NRIX
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FSCC34.830.21
+0.61%
Federated Hermes MDT Small Cap Core ETF
HDEF33.590.10
+0.30%
Xtrackers MSCI EAFE High Div Yld Eq ETF
PFFR17.22N/A
+0.03%
InfraCap REIT Preferred ETF
DVXC23.98N/A
N/A
Webs Defined Volatility Xlc ETF
ONDL5.24-0.05
-0.95%
Defiance Daily Target 2X Long ONDS ETF

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-2.75%
KYMR - NRIX
57%
Loosely correlated
-1.74%
GPCR - NRIX
45%
Loosely correlated
-2.25%
RCUS - NRIX
45%
Loosely correlated
-5.97%
BCYC - NRIX
45%
Loosely correlated
+0.78%
KURA - NRIX
44%
Loosely correlated
-1.56%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with VIR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-5.97%
VIR - RCUS
49%
Loosely correlated
+0.38%
XNCR - RCUS
49%
Loosely correlated
+0.62%
DYN - RCUS
46%
Loosely correlated
-1.14%
AURA - RCUS
44%
Loosely correlated
+0.07%
KURA - RCUS
44%
Loosely correlated
-1.56%
More